Startup Syntax Bio leverages CRISPR to transform cell therapy manufacturing

The latest stories trending on MedCity News.

Editor's Pick

Top Story Startup Syntax Bio Leverages CRISPR to Transform Cell Therapy Manufacturing Syntax Bio's technology platform uses CRISPR to direct stem cells to become a desired cell type in a process that's more scalable and less expensive than current methods. The startup is raising a Series A round of financing to further demonstrate the potential of its technology. Please Tell Us What You Think If you haven't already - You still have time to provide us feedback on what works for you and what doesn't on MedCity News. Please take a few moments to share your thoughts. At the end of the survey, you can enter to win a $250 gift card. Thank you. Take Survey Now

Featured News

How are Employers Responding to Staff Health Needs, Burnout and Helping Them Feel Valued? Although employee stress and burnout are critical issues in all industries, the healthcare industry offers numerous examples of the impact on staff as well as ways to provide short and long-term solutions. These topics will be part of the discussion at the HLTH event October 8-11 in Las Vegas. Register today to join the conversation! How MIPS Value Pathways will Prove the Value of Rehab Therapy As value-based care models take hold, the time is ripe for rehab therapists to position themselves as primary players in the movement toward delivering optimal quality and value in the broader healthcare ecosystem. Zocdoc Takes Aim At Phreesia, NexHealth With New Free Suite of Patient Engagement Tools Zocdoc launched a new suite of tools to compete with the solutions sold by Phreesia, NexHealth and Solutionreach. The product suite, which is free for any provider to use, includes tools to streamline the patient intake process, facilitate online scheduling and enable video visits. Report: 7 Ways Medicare Advantage Is Being Marketed on TV There are concerns that Medicare Advantage TV ads are misleading patients. A new KFF analysis of Medicare Advantage TV ads found that the ads often rely on celebrity endorsements and suggest that seniors are missing out on benefits that they're entitled to.

Resources

Introducing MedCity FemFwd, a New Podcast on Women's Health In the inaugural episode of the MedCity FemFwd podcast, Michelle Long, senior policy analyst for the Women's Health Policy program at KFF, talks about Opill, which recently made headlines as the first daily oral contraceptive approved for nonprescription use in the U.S. Long tells listeners why this news is significant and examines whether the medication will be covered by insurance. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe